Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 792 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact792 DOIs

Add abstracts to 112 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact112 DOIs

Deposit reference lists for 78 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact78 DOIs

DOIs for this ISSN

Showing the top 5 of 1082 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Inflammation as a central mechanism in Alzheimer's disease (10.1016/j.trci.2018.06.014)	ORCID	81.74	1859
2	Alzheimer's disease drug development pipeline: 2019 (10.1016/j.trci.2019.05.008)	ORCID	70.10	636
3	Drug discovery and development: Role of basic biological res… (10.1016/j.trci.2017.10.005)	ORCID	67.45	498
4	Alzheimer's disease drug development pipeline: 2018 (10.1016/j.trci.2018.03.009)	ORCID	66.99	477
5	Alzheimer's disease drug development pipeline: 2022 (10.1002/trc2.12295)	ORCID	66.38	451
6	Alzheimer's disease drug development pipeline: 2020 (10.1002/trc2.12050)	ORCID	64.47	378
7	White matter hyperintensities in vascular contributions to c… (10.1016/j.trci.2019.02.001)	ORCID	64.41	376
8	Alzheimer's disease drug development pipeline: 2021 (10.1002/trc2.12179)	ORCID	64.21	369
9	Marked gender differences in progression of mild cognitive i… (10.1016/j.trci.2015.07.001)	ORCID	63.51	346
10	Alzheimer's disease drug development pipeline: 2023 (10.1002/trc2.12385)	ORCID	63.48	345
11	Erratum: Alzheimer's disease drug development pipeline: 2023 (10.1002/trc2.12407)	Abstract References ORCID	63.38	6
12	Alzheimer's disease drug development pipeline: 2017 (10.1016/j.trci.2017.05.002)	ORCID	62.14	305
13	Neuropsychiatric signs and symptoms of Alzheimer's disease:… (10.1016/j.trci.2017.07.001)	ORCID	61.86	297
14	Disease severity and minimal clinically important difference… (10.1016/j.trci.2019.06.005)	ORCID	61.60	290
15	Optimizing the preclinical Alzheimer's cognitive composite w… (10.1016/j.trci.2017.10.004)	ORCID	60.90	272
16	Alzheimer's disease drug development pipeline: 2024 (10.1002/trc2.12465)	ORCID	60.86	271
17	Recruitment and retention of underrepresented populations in… (10.1016/j.trci.2019.09.018)	ORCID	60.33	258
18	Feasibility and efficacy data from a ketogenic diet interven… (10.1016/j.trci.2017.11.002)	ORCID	59.18	232
19	Racial and ethnic differences in trends in dementia prevalen… (10.1016/j.trci.2018.08.009)	ORCID	59.18	232
20	The roles of inflammation and immune mechanisms in Alzheimer… (10.1016/j.trci.2016.05.001)	ORCID	56.44	180
21	Stereotactic brain injection of human umbilical cord blood m… (10.1016/j.trci.2015.06.007)	ORCID	56.01	173
22	Disease severity and minimal clinically important difference… (10.1002/trc2.12388)	Abstract ORCID	55.70	12
23	First‐in‐human, double‐blind, placebo‐controlled, single‐dos… (10.1016/j.trci.2016.06.002)	ORCID	54.47	150
24	Sedentary behavior as a risk factor for cognitive decline? A… (10.1016/j.trci.2017.04.001)	ORCID	54.18	146
25	The ALFA project: A research platform to identify early path… (10.1016/j.trci.2016.02.003)	ORCID	54.03	144
26	UB‐311, a novel UBITh <sup>®</sup>… (10.1016/j.trci.2017.03.005)	ORCID	53.42	136
27	Racial disparities and temporal trends in dementia misdiagno… (10.1016/j.trci.2019.11.008)	ORCID	53.42	136
28	Speed of processing training results in lower risk of dement… (10.1016/j.trci.2017.09.002)	ORCID	53.18	133
29	Alzheimer's disease drug development pipeline: 2025 (10.1002/trc2.70098)	ORCID	53.10	132
30	Social interaction and cognitive decline: Results of a 7‐yea… (10.1016/j.trci.2016.11.003)	ORCID	52.68	127
31	Multiple comorbid neuropathologies in the setting of Alzheim… (10.1016/j.trci.2016.09.002)	ORCID	52.42	124
32	Digital technologies as biomarkers, clinical outcomes assess… (10.1016/j.trci.2018.04.003)	ORCID	52.34	123
33	Active Aβ immunotherapy CAD106 in Alzheimer's disease: A pha… (10.1016/j.trci.2016.12.003)	ORCID	52.16	121
34	Predicting mild cognitive impairment from spontaneous spoken… (10.1016/j.trci.2017.01.006)	ORCID	52.07	120
35	The effects of noncoding aquaporin‐4 single‐nucleotide polym… (10.1016/j.trci.2017.05.001)	ORCID	52.07	120
36	Global mortality from dementia: Application of a new method… (10.1002/trc2.12200)	ORCID	51.80	117
37	Analysis of dementia in the US population using Medicare cla… (10.1016/j.trci.2019.04.003)	ORCID	51.70	116
38	A systematic review of the use of virtual reality and its ef… (10.1016/j.trci.2019.09.016)	ORCID	51.70	116
39	Synaptic biomarkers in CSF aid in diagnosis, correlate with… (10.1016/j.trci.2019.11.002)	ORCID	51.61	115
40	Electrical brain stimulation in different variants of primar… (10.1016/j.trci.2018.08.002)	ORCID	50.63	105
41	The Alzheimer's Prevention Initiative Generation Program: St… (10.1016/j.trci.2019.02.005)	ORCID	50.32	102
42	Measuring cognition and function in the preclinical stage of… (10.1016/j.trci.2018.01.003)	ORCID	50.22	101
43	The Alzheimer's Prevention Initiative Autosomal‐Dominant Alz… (10.1016/j.trci.2018.02.002)	ORCID	50.11	100
44	The role of acetylcholinesterase inhibitors such as neostigm… (10.1016/j.trci.2019.03.004)	ORCID	49.89	98
45	Alzheimer's disease in Down syndrome: An overlooked populati… (10.1016/j.trci.2018.10.006)	ORCID	49.78	97
46	The Sant Pau Initiative on Neurodegeneration (SPIN) cohort:… (10.1016/j.trci.2019.09.005)	ORCID	49.78	97
47	Convolution neural network–based Alzheimer's disease classif… (10.1016/j.trci.2019.10.001)	ORCID	49.78	97
48	Web‐enabled conversational interactions as a method to impro… (10.1016/j.trci.2015.01.001)	ORCID	49.56	95
49	A randomized, double‐blind, placebo‐controlled trial of resv… (10.1016/j.trci.2018.09.009)	ORCID	49.56	95
50	Lower brain and blood nutrient status in Alzheimer's disease… (10.1016/j.trci.2017.06.002)	ORCID	49.44	94